Dr. Samer D. Tabbal, MD

Dr. Tabbal practices at Baptist Outpatient Services Inc in Miami, Florida.

Dr. Tabbal's NPI, 1053337279, was assigned on July 14, 2006. Dr. Tabbal graduated from American University of Beirut Faculty of Medicine in 1993. Dr. Tabbal holds Florida license ME169284.

Dr. Tabbal's primary practice is Baptist Outpatient Services Inc, at 8950 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 204-4204.

Dr. Tabbal's primary practice is Baptist Outpatient Services Inc in Miami, Florida. Dr. Tabbal is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Tabbal to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabbal practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tabbal's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tabbal is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Tabbal's licenses on file in 5 states: Florida, Missouri, Pennsylvania, Arkansas and New Jersey.

Dmand AI lists epilepsy, essential tremor, fibromyalgia and chronic pain, headaches, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Dr. Tabbal treats.

CMS data shows 210 Medicare services from Dr. Tabbal across 5 procedure codes in 2024, for 228 Medicare patients. Medicare paid $18,127 for them.

CMS counts 228 Medicare patients who saw Dr. Tabbal in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tabbal's median patient age at 70, with 59% women.

In 2024, Dr. Tabbal wrote 2,134 Medicare Part D claims for 360 patients. 85% of them were for generic drugs. CMS names the drug for 2,032 of them, across 35 drugs with 11 or more claims each, at $1,342,501 in total drug cost. In 2023, CMS named 2,323 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Tabbal for performance year 2024, reported through an alternative payment model (APM). Dr. Tabbal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tabbal as offering telehealth.

Dmand AI links 45 papers to Dr. Tabbal, published from 2006 to 2024. 2012 was the busiest year, with 5. The most frequent topics are Deep Brain Stimulation, Parkinson Disease and Subthalamic Nucleus. Dr. Tabbal has published most often in Exp Neurol. Dr. Tabbal's most frequent co-authors are Jonathan W. Mink, MD, PhD, Mwiza Ushe, MD and Daniel Dung Truong, MD.

CMS Open Payments shows 16 general payments to Dr. Tabbal from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $253.

Dr. Tabbal graduated from American University of Beirut Faculty of Medicine in 1993.

Dr. Tabbal is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.